Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Higgins

Showing results (61-70 of 63) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 63 results.
Journal of Neurosurgery. Spine|August 20, 2021
A multicenter analysis of the prognostic value of histone H3 K27M mutation in adult high-grade spinal gliomaOluwaseun O Akinduro, Diogo P Garcia, Dominique M O Higgins, et al.
Biorxiv : the Preprint Server for Biology|March 3, 2023
A cell state specific metabolic vulnerability to GPX4-dependent ferroptosis in glioblastomaMatei A Banu, Athanassios Dovas, Michael G Argenziano, et al.
The Lancet. Oncology|October 15, 2022
Chronic convection-enhanced delivery of topotecan for patients with recurrent glioblastoma: a first-in-patient, single-centre, single-arm, phase 1b trialEleonora F Spinazzi, Michael G Argenziano, Pavan S Upadhyayula, et al.
Pageof 7

Showing results (61-70 of 63) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 63 results.
Journal of Neurosurgery. Spine|August 20, 2021
A multicenter analysis of the prognostic value of histone H3 K27M mutation in adult high-grade spinal gliomaOluwaseun O Akinduro, Diogo P Garcia, Dominique M O Higgins, et al.
Biorxiv : the Preprint Server for Biology|March 3, 2023
A cell state specific metabolic vulnerability to GPX4-dependent ferroptosis in glioblastomaMatei A Banu, Athanassios Dovas, Michael G Argenziano, et al.
The Lancet. Oncology|October 15, 2022
Chronic convection-enhanced delivery of topotecan for patients with recurrent glioblastoma: a first-in-patient, single-centre, single-arm, phase 1b trialEleonora F Spinazzi, Michael G Argenziano, Pavan S Upadhyayula, et al.
Pageof 7